Status:
RECRUITING
Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
Lead Sponsor:
University of Louisville
Conditions:
Relapsing Remitting Multiple Sclerosis
Eligibility:
FEMALE
18-50 years
Brief Summary
The investigators' overall hypothesis is that appearance or worsening of relapsing-remitting multiple sclerosis (RR-MS) symptoms are affected by various factors including stress, hormonal cycles, illn...
Detailed Description
Fluctuations in MS symptoms in women with RR-MS might be affected by a variety of factors. To determine which factors are important, we are asking subjects to fill out a diary and calendar on a daily ...
Eligibility Criteria
Inclusion
- females
- diagnosed with relapsing-remitting multiple sclerosis
Exclusion
- male
- no diagnosis of relapsing-remitting MS
- diagnosis of any other autoimmune disease or fibromyalgia
- peri-, post-, or surgically menopausal
- pregnant within past year or nursing
- history of chemotherapy
- on experimental medications
- treatment with steroids in the last 30 days
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00919217
Start Date
August 1 2008
End Date
December 1 2025
Last Update
February 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Louisville (recruiting nationwide)
Louisville, Kentucky, United States, 40292